Endoscopy 2017; 49(05): 429-437
DOI: 10.1055/s-0043-101685
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Evaluation of narrow-band imaging signs in eosinophilic and lymphocytic esophagitis

Tamaki Ichiya
1   Department of Medicine Solna, Karolinska Institutet, Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden
,
Kyosuke Tanaka
2   Department of Endoscopy, Mie University Hospital, Mie, Japan
,
Carlos A. Rubio
3   Department of Pathology, Karolinska University Hospital, Stockholm, Sweden
,
Ulf Hammar
4   Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
,
Peter T. Schmidt
1   Department of Medicine Solna, Karolinska Institutet, Center for Digestive Diseases, Karolinska University Hospital, Stockholm, Sweden
› Author Affiliations
Further Information

Publication History

submitted 23 June 2016

accepted after revision 17 December 2016

Publication Date:
15 February 2017 (online)

Abstract

Background and study aims No specific endoscopic signs for diagnosing eosinophilic esophagitis (EoE) have been described and very few studies have reported endoscopic signs for lymphocytic esophagitis (LyE). This study aimed to assess the utility of narrow-band imaging magnifying endoscopy (NBI-ME) in predicting EoE/LyE diagnosis before histopathological assessment.

Patients and methods Adult patients with dysphagia and/or food impaction who underwent esophagogastroduodenoscopy followed by NBI-ME and biopsies were included. Three previously reported NBI-ME signs were studied: beige mucosa, dot-shaped intra-epithelial papillary capillary loop (IPCL), and absent cyan vessels. These signs were compared with the histological diagnosis, and studied in patients with and without EoE or LyE. A predictive model containing the NBI-ME signs was analyzed, based on area under the curve (AUC).

Results A total of 137 patients were enrolled. Based on histology 26 were diagnosed with EoE, 26 with LyE, and 85 were control patients with neither diagnosis. Significantly more EoE/LyE patients than control patients showed the NBI signs (P  < 0.001 for all three signs). Absent cyan vessels had the highest accuracy for differentiation (sensitivity 88 %, specificity 92 %). A combination of age, dot IPCLs, and absent cyan vessels was highly predictive of EoE/LyE, with an AUC of 0.952.

Conclusions Three NBI-ME signs were found in the majority of patients with EoE/LyE and unlikely to be observed in controls. A combination of two NBI-ME signs and younger age had a higher degree of accuracy. This supports the claim that NBI-ME could be a reliable diagnostic modality for EoE/LyE predictors.

Table e4 – e5

 
  • References

  • 1 Attwood SE, Smyrk TC, Demeester TR. et al. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993; 38: 109-116
  • 2 Liacouras CA, Furuta GT, Hirano I. et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 2011; 128: 3-20
  • 3 Dellon ES, Gonsalves N, Hirano I. et al. ACG clinical guideline: Evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 2013; 108: 679-692
  • 4 Dellon ES, Gibbs WB, Fritchie KJ. et al. Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease. Clin Gastroenterol Hepatol 2009; 7: 1305-1313
  • 5 von Arnim U, Wex T, Rohl FW. et al. Identification of clinical and laboratory markers for predicting eosinophilic esophagitis in adults. Digestion 2011; 84: 323-327
  • 6 Dellon ES, Rusin S, Gebhart JH. et al. A clinical prediction tool identifies cases of eosinophilic esophagitis without endoscopic biopsy: a prospective study. Am J Gastroenterol 2015; 110: 1347-1354
  • 7 Rubio CA, Sjodahl K, Lagergren J. Lymphocytic esophagitis: a histologic subset of chronic esophagitis. Am J Clin Pathol 2006; 125: 432-437
  • 8 Dellon ES. Diagnosis and management of eosinophilic esophagitis. Clin Gastroenterol Hepatol 2012; 10: 1066-1078
  • 9 Haque S, Genta RM. Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition. Gut 2012; 61: 1108-1114
  • 10 Cohen S, Saxena A, Waljee AK. et al. Lymphocytic esophagitis: a diagnosis of increasing frequency. J Clin Gastroenterol 2012; 46: 828-832
  • 11 Dellon ES, Aderoju A, Woosley JT. et al. Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review. Am J Gastroenterol 2007; 102: 2300-2313
  • 12 Hirano I, Moy N, Heckman MG. et al. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut 2013; 62: 489-495
  • 13 van Rhijn BD, Warners MJ, Curvers WL. et al. Evaluating the endoscopic reference score for eosinophilic esophagitis: moderate to substantial intra- and interobserver reliability. Endoscopy 2014; 46: 1049-1055
  • 14 Kim HP, Vance RB, Shaheen NJ. et al. The prevalence and diagnostic utility of endoscopic features of eosinophilic esophagitis: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 988-996
  • 15 Peery AF, Cao H, Dominik R. et al. Variable reliability of endoscopic findings with white-light and narrow-band imaging for patients with suspected eosinophilic esophagitis. Clin Gastroenterol Hepatol 2011; 9: 475-480
  • 16 Kumagai Y, Inoue H, Nagai K. et al. Magnifying endoscopy, stereoscopic microscopy, and the microvascular architecture of superficial esophageal carcinoma. Endoscopy 2002; 34: 369-375
  • 17 Rey JF, Inoue H, Guelrud M. Magnification endoscopy with acetic acid for Barrett’s esophagus. Endoscopy 2005; 37: 583-586
  • 18 Santi EG, Inoue H, Ikeda H. et al. Microvascular caliber changes in intramucosal and submucosally invasive esophageal cancer. Endoscopy 2013; 45: 585-588
  • 19 Tanaka K, Rubio CA, Dlugosz A. et al. Narrow-band imaging magnifying endoscopy in adult patients with eosinophilic esophagitis/esophageal eosinophilia and lymphocytic esophagitis. Gastrointest Endosc 2013; 78: 659-664
  • 20 Dellon ES, Speck O, Woodward K. et al. Clinical and endoscopic characteristics do not reliably differentiate PPI-responsive esophageal eosinophilia and eosinophilic esophagitis in patients undergoing upper endoscopy: a prospective cohort study. Am J Gastroenterol 2013; 108: 1854-1860
  • 21 Moawad FJ, Schoepfer AM, Safroneeva E. et al. Eosinophilic oesophagitis and proton pump inhibitor-responsive oesophageal eosinophilia have similar clinical, endoscopic and histological findings. Aliment Pharm Ther 2014; 39: 603-608
  • 22 Warners MJ, van Rhijn BD, Curvers WL. et al. PPI-responsive esophageal eosinophilia cannot be distinguished from eosinophilic esophagitis by endoscopic signs. Eur J Gastroenterol Hepatol 2015; 27: 506-511
  • 23 Eluri S, Dellon ES. Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences. Curr Opin Gastroenterol 2015; 31: 309-315
  • 24 Rubio CA, Ichiya T, Schmidt PT. Lymphocytic oesophagitis, eosinophilic oesophagitis and compound lymphocytic-eosinophilic oesophagitis I: histological and immunohistochemical findings. J Clin Pathol 2016; DOI: 10.1136/jclinpath-2016-203782.
  • 25 Armstrong D, Bennett JR, Blum AL. et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92
  • 26 DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-845
  • 27 Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174
  • 28 Zou G, Donner A. Confidence interval estimation of the intraclass correlation coefficient for binary outcome data. Biometrics 2004; 60: 807-811
  • 29 Dellon ES, Cotton CC, Gebhart JH. et al. Accuracy of the Eosinophilic Esophagitis Endoscopic Reference Score in diagnosis and determining response to treatment. Clin Gastroenterol Hepatol 2016; 14: 31-39
  • 30 Pasha SF, Acosta RD, Chandrasekhara V. et al. The role of endoscopy in the evaluation and management of dysphagia. Gastrointest Endosc 2014; 79: 191-201
  • 31 Wen T, Stucke EM, Grotjan TM. et al. Molecular diagnosis of eosinophilic esophagitis by gene expression profiling. Gastroenterology 2013; 145: 1289-1299
  • 32 Huang JJ, Joh JW, Fuentebella J. et al. Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of eosinophilic esophagitis. Allergy Asthma Clin Immunol 2010; 6: 25
  • 33 Johnsson M, Bove M, Bergquist H. et al. Distinctive blood eosinophilic phenotypes and cytokine patterns in eosinophilic esophagitis, inflammatory bowel disease and airway allergy. J Innate Immun 2011; 3: 594-604
  • 34 Mulder DJ, Hurlbut DJ, Noble AJ. et al. Clinical features distinguish eosinophilic and reflux-induced esophagitis. J Pediatr Gastroenterol Nutr 2013; 56: 263-270